CCTG at European Society for Medical Oncology Congress 2025

CCTG CO.29 - Circulating Tumor DNA Analysis Informing Adjuvant Chemotherapy in Stage III Colon Cancer: A Multicentre Phase II/III Randomised Controlled Study (DYNAMIC III)

Session Type:    Oral Session presented as part of the Presidential Symposium

Abstract:          LBA9 - CO.29 ctDNA-guided adjuvant chemotherapy de-escalation in stage III colon cancer: Primary analysis of the ctDNA-negative cohort from the randomized AGITG DYNAMIC-III trial (Intergroup study of AGITG and CCTG).

Authors:              Jeanne Tie (Melbourne, Australia, VIC),  Yuxuan Wang (Baltimore, US), Jonathan M. Loree (Vancouver, Canada), Joshua Cohen (Baltimore, US), David Espinoza (Camperdown, Australia), Rachel Wong (Box Hill, Australia), Timothy J. Price (Woodville, Australia), Niall Tebbutt (Heidelberg, Australia), Matthew Burge (Herston, Australia), James Lynam (Waratah, Australia), Belinda Lee (Melbourne, Australia), Samuel J. Harris (Bendigo, Australia), Lorraine Chantrill (Wollongong, Australia), Daniel A. Breadner (London, Canada), Christopher O'Callaghan (Kingston, Canada), Chetan Bettegowda (Baltimore, US), Nicholas Papadopoulos (Baltimore, US), Kenneth Kinzler (Baltimore, US), Bert Vogelstein (Baltimore, US), Peter Gibbs (Parkville, Australia) 

 Website Link:   https://cslide.ctimeetingtech.com/esmo2025/attendee/confcal/session/list?q=LBA9

CCTG CO.21 - A Phase III Study of the Impact of a Physical Activity Program on Disease-Free Survival in Patients with High Risk Stage II or Stage III Colon Cancer: A Randomized Controlled Trial (CHALLENGE)

Session Type:    Mini Oral Session GI tumours, lower digestive     

Abstract :          LBA28 - Predictors of adherence to the structured exercise program and physical activity target in the Canadian Cancer Trials Group CO.21 CHALLENGE trial.

Authors:              Christopher M. Booth (Kingston, Canada) Janette Vardy (Concord, Australia, Ontario) Christopher O'Callaghan (Kingston, Canada) Sharlene Gill (Vancouver, Canada, British Columbia) Rebecca K. Wong (Toronto, Canada) Haryana Dhillon (Sydney, Australia) Christine Friendenreich (Calgary, Canada) Victoria Coyle (Belfast, United Kingdom, UK) Neil Chua (Edmonton, Canada) Derek Jonker (Ottawa, Canada) Shahid Ahmed (Saskatoon, Canada) Anthony Reiman (Saint John, Canada) Kristin Campbell (Vancouver, Canada) Fernanda Arthuso (Edmonton, Canada) John R. Zalcberg (Melbourne, Australia, VIC) Stephen Clarke (St Leonards, Australia, NSW) Stephen Begbie (Port Macquarie, Australia, NSW) Patti O'Brien (Kingston, Canada) Dongsheng Tu (Kingston, Canada) Kerry Courneya (Edmonton, Canada) 

Website Link:     https://cslide.ctimeetingtech.com/esmo2025/attendee/confcal/session/list?q=LBA28 

CCTG BR.31 - A Phase III Prospective Double Blind Placebo Controlled Randomized Study of Adjuvant MEDI4736 in Completely Resected Non-Small Cell Lung Cancer

Session Type:    Mini Oral Non-metastatic NSCLC

Abstract :          LBA68 - CCTG BR.31: Adjuvant durvalumab (D) in resected non-small-cell lung cancer (NSCLC): Final overall survival (OS) and minimal residual disease (MRD) analyses.

Authors:             Glenwood Goss (Ottawa, Canada), Gail Darling (Halifax, Canada), Virginie Westeel (Besancon, France), Kazuhiko Nakagawa (Osaka, Japan), Bartomeu Massuti Sureda (Alicante, Spain), Francesco Perrone (Napoli, Italy), Sue-Anne McLachlan (Melbourne, Australia), Jin H. Kang (Seoul, Republic of Korea), Yi-Long Wu (Guangzhou, China), Anne-Marie C. Dingemans (Rotterdam, Netherlands), Rafal Dziadziuszko (Gdansk, Poland), Morihito Okada (Hiroshima, Japan), Laurent Greillier (Marseille, France), Clarisse Audigier-Valette (Toulon, France), Shunichi Sugawara (Sendai, Japan, Miyagi), Ernest Nadal (L'Hospitalet de Llobregat, Spain), Annamaria Catino (Bari, Italy), Martin R. Stockler (Camperdown, Australia), Keyue U. Ding (Kingston, Canada), Christopher O'Callaghan (Kingston, Canada) 

Website Link:    https://cslide.ctimeetingtech.com/esmo2025/attendee/confcal/session/list?q=LBA68

CCTG PR.21 - A Randomized Phase II Study of 177Lu-PSMA-617 vs Docetaxel in Patients with Metastatic Castration-Resistant Prostate Cancer and PSMA-Positive Disease

Session Type:    Oral proffered paper session radioligand therapeutics

Abstract:          LBA89 -  A randomized phase II study of 177Lu-PSMA-617 vs docetaxel in patients with metastatic castration-resistant prostate cancer (mCRPC) and PSMA-positive disease: Canadian Cancer Trials Group (CCTG) study PR.21

Authors:              Kim Nguyen Chi (Vancouver, Canada), Fred Saad (Montreal, Canada), Keyue U. Ding (Kingston, Canada), Glenn Bauman (London, Canada), Urban Emmenegger (Toronto, Canada), Sebastien J. Hotte (Hamilton, Canada), Frederic Pouliot (Quebec City, Canada), Justin Lee (Vancouver, Canada), Jean-Mathieu Beauregard (Quebec City, Canada), Lucia Nappi (Vancouver, Canada), Christian K. Kollmannsberger (Vancouver, Canada), Zineb Hamilou (Montreal, Canada), Gad Abikhzer (Montreal, Canada), Michel Pavic (Quebec, Canada), Scott North (Edmonton, Canada), Di Maria Jiang (Toronto, Canada), Steven M. Yip (Calgary, Canada), Conor Dellar (Kingston, Canada), Wendy R. Parulekar (Kingston, Canada), Francois Benard (Vancouver, Canada) 

Website Link:     https://cslide.ctimeetingtech.com/esmo2025/attendee/confcal/session/list?q=LBA89

CCTG MAC.18 (ALLIANCE A221405) - POSITIVE: A Study Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Young Women with Endocrine Responsive Breast Cancer who Desire Pregnancy

Session Type:    Proffered Paper session: Breast cancer, early stage

Abstract:          LBA12 - 5-year follow-up results from the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) trial

Authors:             Fedro A. Peccatori (Milan, Italy), Olivia Pagani (Rennaz, Switzerland), Samuel M. Niman (Boston, US), Monica Ruggeri (Bern, Switzerland), Hatem A. Azim (Cairo, Egypt), Marco A. Colleoni (Milan, Italy), Cristina Saura Manich (Barcelona, Spain), Chikako Shimizu (Shinjuku-ku, Japan), Anna Satersdal (Oslo, Norway), Judith R. Kroep (Leiden, Netherlands), Ellen Warner (Toronto, Canada), Audrey Mailliez (Lille, France), Frederic Amant (Leuven, Belgium), Teresa Ferreiro (Barcelona, Spain), Martine Piccart (Anderlecht, Belgium), Larissa A. Korde (Bethesda, US), Aron Goldhirsch (Milan, Italy), Richard D. Gelber (Boston, US), Ann H. Partridge (Boston, US) 

Website Link:   https://cslide.ctimeetingtech.com/esmo2025/attendee/confcal/session/list?q=LBA12